Journal article
Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
Genome research, Vol.20(11), pp.1482-1492
11/01/2010
DOI: 10.1101/gr.107672.110
PMCID: PMC2963812
PMID: 20923822
Abstract
Radiation therapy is used to treat half of all cancer patients. Response to radiation therapy varies widely among patients. Therefore, we performed a genome-wide association study (GWAS) to identify biomarkers to help predict radiation response using 277 ethnically defined human lymphoblastoid cell lines (LCLs). Basal gene expression levels and 1.3 million genome-wide single nucleotide polymorphism (SNP) markers from both Affymetrix and Illumina platforms were assayed for all 277 human LCLs. MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assays for radiation cytotoxicity were also performed to obtain area under the curve (AUC) as a radiation response phenotype for use in the association studies. Functional validation of candidate genes, selected from an integrated analysis that used SNP, expression, and AUC data, was performed with multiple cancer cell lines using specific siRNA knockdown, followed by MTS and colony-forming assays. A total of 27 loci, each containing at least two SNPs within 50 kb with
P
-values less than 10
−4
were associated with radiation AUC. A total of 270 expression probe sets were associated with radiation AUC with
P
< 10
−3
. The integrated analysis identified 50 SNPs in 14 of the 27 loci that were associated with both AUC and the expression of 39 genes, which were also associated with radiation AUC (
P
< 10
−3
). Functional validation using siRNA knockdown in multiple tumor cell lines showed that
C13orf34
,
MAD2L1
,
PLK4
,
TPD52
, and
DEPDC1B
each significantly altered radiation sensitivity in at least two cancer cell lines. Studies performed with LCLs can help to identify novel biomarkers that might contribute to variation in response to radiation therapy and enhance our understanding of mechanisms underlying that variation.
Details
- Title: Subtitle
- Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
- Creators
- Nifang Niu - Mayo ClinicYuxin Qin - Mayo ClinicBrooke L. Fridley - Mayo Clinic in FloridaJunmei Hou - Mayo ClinicKrishna R. Kalari - Mayo Clinic in FloridaMinjia ZhuTse-Yu Wu - Mayo ClinicGregory D. Jenkins - Mayo Clinic in FloridaAnthony Batzler - Mayo Clinic in FloridaLiewei Wang - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Genome research, Vol.20(11), pp.1482-1492
- DOI
- 10.1101/gr.107672.110
- PMID
- 20923822
- PMCID
- PMC2963812
- NLM abbreviation
- Genome Res
- ISSN
- 1088-9051
- eISSN
- 1549-5469
- Publisher
- Cold Spring Harbor Laboratory Press
- Number of pages
- 11
- Alternative title
- Niu et al
- Language
- English
- Date published
- 11/01/2010
- Academic Unit
- Stead Family Department of Pediatrics; Medical Genetics and Genomics
- Record Identifier
- 9984701542002771
Metrics
4 Record Views